Format

Send to

Choose Destination
See comment in PubMed Commons below
Arch Fam Med. 1992 Nov;1(2):233-7.

Effects of differing nicotine-replacement doses on weight gain after smoking cessation.

Author information

1
Center for Pulmonary Disease Prevention, Palo Alto, Calif.

Abstract

OBJECTIVE:

To prospectively assess effects of doses of a nicotine-replacement agent on weight gain in men and women after smoking cessation.

DESIGN:

Four-week, randomized, double-blind clinical trial.

SETTING:

Outpatient medical clinic.

STUDY PARTICIPANTS:

Healthy volunteers who smoked at least 10 cigarettes per day.

INTERVENTION:

Pharmacologic: Random assignment to 0, 2, or 4 mg of nicotine polacrilex on a fixed-dose schedule (one piece per hour while awake). Behavioral: Brief, medical/behavioral counseling regarding smoking cessation.

MAIN OUTCOME MEASURE:

Weight change as a function of dose and gender only in participants abstinent for all 4 week. (Self-reported abstinence verified by breath carbon monoxide levels).

RESULTS:

Weight change in women abstinent for 4 weeks (n = 16) was +1.69, +0.33, and -0.26 kg in the placebo, 2-mg, and 4-mg groups, respectively, compared with +1.60, +1.45, and +1.18 kg for the men who were abstinent for 4 weeks (n = 19). Medication use did not differ as a function of dose or gender.

CONCLUSIONS:

Nicotine polacrilex suppressed, in a dose-related fashion, weight gain after smoking cessation in successfully treated women. Weight gain was not shown to be suppressed in men, possibly because of small sample size.

PMID:
1341599
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center